FDA Approvals

Date Posted
Article Title
1/25/2013
1st OTC Drug Approved for Women With Overactive Bladder

Oxytrol is intended for use by those 18 and older

1/23/2013
Drug Approved for Inherited Blood Disorder

Exjade removes excess iron, FDA says

1/22/2013
Botox Approved for Overactive Bladder

When people don't respond to standard treatments

1/17/2013
Octaplas Approved for Blood-Clotting Disorders

Made from treated human plasma

1/17/2013
Flublok Approved to Prevent Seasonal Flu

New vaccine doesn't use flu virus or eggs, could speed up production

1/3/2013
Eliquis Approved for People With Heart Rhythm Disorder

To help prevent stroke and deadly blood clots

1/2/2013
Fulyzaq Approved for Diarrhea in People With HIV/AIDS

Antiretroviral drugs can lead to diarrhea

1/2/2013
Sirturo Approved for Multi-Drug Resistant TB

Millions still contract the infectious disease each year

1/2/2013
Juxtapid Approved for LDL Cholesterol Condition

Disorder affects about 1 million in U.S.

12/21/2012
Varizig Approved to Treat Chickenpox Symptoms

Within four days of exposure

12/21/2012
Tamiflu Approval Expanded to Include Infants Under Age 1

First approved in 1999 for adults with flu

12/21/2012
Gattex Approved for Short Bowel Syndrome

Provides nutrition for people with surgically removed intestine

12/17/2012
Signifor Approved for Cushing's Disease

In cases that cannot be treated through surgery

12/14/2012
Raxibacumab Approved for Inhalational Anthrax

Neutralizes anthrax toxins, which can kill

12/14/2012
Iclusig Approved for Rare Leukemias

Blocks proteins that spur cancer development

12/10/2012
Zytiga's Use Expanded for Advanced Prostate Cancer

Decreases body's production of testosterone

11/29/2012
Cometriq Approved for Rare Thyroid Cancer

Drug designed to inhibit tumor growth

11/21/2012
11/20/2012
11/15/2012
Drug-Eluting Stent Approved for Peripheral Arterial Disease

Coated hollow tube props open thigh artery